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CD8+CD122+ T-cells have been traditionally described as antigen-specific memory 
T-cells that respond to previously encountered antigens more quickly and vigorously than 
their naïve counterparts. However, mounting evidence has demonstrated that murine 
CD8+CD122+ T-cells exhibit a central memory phenotype (CD44highCD62Lhigh), regulate 
T cell homeostasis, and act as regulatory T-cells (Treg) by suppressing both autoimmune 
and alloimmune responses. Importantly, naturally occurring murine CD8+CD122+ Tregs 
are more potent in immunosuppression than their CD4+CD25+ counterparts. They appear 
to be acting in an antigen-non-specific manner. Human CD8+CXCR3+ T-cells are the 
equivalent of murine CD8+CD122+ Tregs and also exhibit central memory phenotypes. 
In this mini-review article, we will summarize recent progresses in their phenotypes, 
homeostatic expansion, antigen-specificity, roles in the suppression of alloimmune and 
autoimmune responses, and the mechanisms underlying their inhibitory function.
Keywords: regulatory T-cells, CD8+CD122+ T-cells, immunoregulation, allograft survival, transplant tolerance, 
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introduction
Upon reencounter with previously recognized antigens, memory T-cells respond more rapidly and 
vigorously than their naïve counterparts. They are somewhat resistant to immunosuppression, such 
as costimulatory blockade (1, 2). Memory T-cells can rapidly trigger alloimmune responses through 
the production of various inflammatory cytokines (3). Previous studies have also shown that early 
infiltration of CD8+ memory T-cells into allografts, including hearts, kidneys, and livers, facilitates 
allograft rejection and presents a hurdle to achieving long-term allograft survival (4–6). Therefore, 
they are generally considered as a major barrier to long-term allograft survival or tolerance (7). 
In particular, CD8+CD122+ T-cells have previously been described as antigen-specific memory 
T-cells (8–10). However, emerging evidence has shown that central memory CD8+CD122+ T-cells 
(CD44highCD62Lhigh) also play a role in regulating T cell homeostasis and serve as regulatory T-cells 
(Tregs). Since original studies revealed that CD8+ T-cells exhibit Treg properties (11–13), more 
and more studies have confirmed their immunosuppressive activities. Suzuki’s research group has 
provided the early evidence that CD8+CD122+ T-cells maintain T cell homeostasis (14), whereas 
more recent studies have suggested that CD8+CD122+ T-cells are Tregs that suppress conventional 
Abbreviations: EAE, experimental autoimmune encephalomyelitis; NO, nitric oxide; PD-1, programed death-1; Treg, regula-
tory T cell.
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T cell responses (14–20) and control autoimmune diseases 
(21, 22). We have found that memory CD8+CD122+ T-cells as 
well as bystander central memory CD8+ T-cells are also Tregs that 
inhibit murine allograft rejection (23, 24). Moreover, others have 
shown that central memory CD8+ T-cells mediate lung allograft 
acceptance (25). Therefore, CD8+CD122+ Tregs may corre-
spond to their CD4+CD25+FoxP3+ counterparts since CD122 
is β subunit of IL-2 receptor, whereas CD25 is an α subunit of 
the same receptor on T cells (26). More importantly, we have 
recently demonstrated that CD8+CD122+ Tregs are more potent 
in their suppression of allograft rejection than their CD4+CD25+ 
counterparts (27). Hence, not only are memory CD8+CD122+ 
T-cells Tregs but can also boost the strength of Treg-mediated 
regulation.
Although CD8+CD122+ Tregs may regulate immune 
responsiveness by production of IL-10, TGFβ1, and IFNγ, 
the exact mechanisms underlying their suppression are 
still largely unknown. More studies are required to fully 
understand their mechanisms and clearly distinguish 
between effectors and regulators that originate from memory 
CD8+CD122+ T-cells, although PD-1 expression recently has 
been shown to define CD8+CD122+ T-cells as the memory 
versus Tregs (24). In this mini-review article, we will briefly 
summarize new progresses in their phenotypes, antigen 
specificity, roles in the suppression of alloimmune and auto-
immune responses, and immune mechanisms underlying 
their inhibitory function.
CD8+CD122+ Treg Phenotypes
Mounting evidence has suggested that CD8+CD122+ T-cells 
are Tregs, which can suppress both autoimmunity and 
alloimmunity. They exhibit memory-like T cell phenotypes 
with regulatory functions. Murine CD8+CD122+ Tregs 
express CD122 (IL-2Rβ) and CXCR3, but not CD25, whereas 
their CD4+CD25+ counterparts do not express CD122. 
CD8+CD122+ Tregs are also CD44high, CD62Lhigh CCR7+, 
and largely CD127− (24, 28). However, CD8+CD122+ Tregs 
are FoxP3-negative (24), indicating that they are a different 
subset from inducible CD8+FoxP3+ Tregs (29). Memory-like 
CD8+CD122+ T-cells, which also express CD38, suppress 
CD4+ T-cell activation (30), whereas another subset of CD8+ 
Tregs carry both CD122 surface marker and the class-I MHC 
receptor Ly49 (21). We have previously shown that PD-1 
expression defines CD8+CD122+ T-cells as Tregs versus 
memory T-cells (24).
Human equivalent of murine CD8+CD122+ Tregs has also 
recently been characterized. They exhibit an in vitro suppres-
sive property with phenotypes of CD8+CXCR3+CD45RA− 
and largely CD62L+ or CCR7+, but do not express CD122 
(31). However, it remains to be defined if CXCR3 expression 
alone can distinguish memory from regulatory human 
CD8+ T-cells since effector CD8+ T-cells may also express 
CXCR3. Taken together, both murine CD8+CD122+ and 
human CD8+CXCR3+ Tregs exhibit the phenotypes of central 
memory T-cells.
Age-Associated Distribution and naturally 
Arising Features of Murine CD8+CD122+ 
Tregs
The percentages of CD122+ T-cells within CD8+ population 
fluctuate between 10 and 50%, depending on mouse age. 
Overall, the percentages of CD122+ T-cells in CD8+ popula-
tion are very high in young mice, reduced to the lowest level 
of ~10% at the age of 8–10  weeks, and then increased with 
aging, exhibiting a pattern of two age-related phases (14). A 
high rate of CD8+CD122+ T-cells in young mice may represent a 
regulatory cell component since previous studies and ours have 
proved that these cells derived from young mice are indeed 
Tregs, whereas the increased number of CD8+CD122+ T-cells 
at old age could be due to the increase in memory CD8+CD122+ 
T-cells. It remains to be determined if the latter are regulatory 
or memory T-cells and if they contain both components. On 
the other hand, CD8+CD122+ T-cells that are proved to be Tregs 
have been isolated, to our knowledge, from naïve mice, suggest-
ing that they are indeed naturally arising cells. However, it is 
unknown whether CD8+CD122+ Tregs can be induced in vitro 
and in vivo. It is also unclear if they exhibit the same phenotypes 
upon expansion in  vitro or in  vivo. These questions warrant 
further investigations given that CD8+CD122+ Tregs are more 
efficient but yet less studied than conventional CD4+CD25+ 
Tregs.
Homeostasis and expansion of Memory-
Like CD8+CD122+ Tregs
IL-15 is essential for the generation and survival of memory 
CD8+ T-cells (32, 33) while administration of recombinant 
IL-15 significantly augments their numbers (8, 34). We have 
demonstrated that administration of IL-15 expands adoptively 
transferred CD8+CD122+ Tregs and enhances their suppres-
sion of allograft rejection (27). We have also found that IL-15 
promotes their expansion in vitro as well, suggesting that IL-15 
provides a critical signal that drives homeostatic expansion of 
memory-like murine CD8+CD122+ Tregs. However, it remains to 
be defined if IL-15 also drives homeostatic expansion of human 
CD8+CXCR3+ Tregs. IL-15 may not do so since they do not 
express CD122. In order to enhance Treg suppression in a clinic 
setting, further studies are warranted to identify signals that are 
required for homeostatic expansion of human CD8+CXCR3+ 
Tregs.
Since IL-15 can expand both memory CD8+ T-cells and 
CD8+CD122+ Tregs, it may act as a double-edged sword in the 
face of an allograft. It would be difficult to use IL-15 to promote 
CD8+CD122+ Treg-mediated graft acceptance without expand-
ing memory CD8+ T-cells. Recent studies have shown that 
administration of IL-15 enhances anti-tumor immunity when 
blocking CD8+CD122+ Treg function (35). In those studies, IL-15 
enhanced memory CD8+ T-cell function, but not CD8+CD122+ 
Treg suppression, given that Tregs were inhibited by PD-1 signal-
ing blockade. In a transplant setting, however, we need to boost the 
Treg suppression. We have previously succeeded in utilizing low 
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doses of IL-15 to promote adoptively transferred CD8+CD122+ 
Treg suppression of allograft rejection (27), indicating that when 
CD8+CD122+ Tregs are transferred in large numbers, IL-15 
likely promotes the expansion of more CD8+CD122+ Tregs than 
endogenous memory CD8+ T-cells.
is CD8+CD122+ Treg-Mediated 
Suppression Antigen-Specific?
It remains to be defined if the immunosuppression mediated by 
murine CD8+CD122+ Tregs is antigen specific. Recent studies 
have shown that CD8+CD122+ Tregs exhibit CDR3 sequences 
of T-cell receptor β chain (36), and that the distribution of 
the CDR3 length is following a Gaussian-like one, except for 
Vb13. Based on this original study, it is possible that murine 
CD122+CD8+ T-cells are not selected in the thymus. Moreover, 
we have demonstrated that bystander memory CD8+ T-cells 
with central memory phenotypes can inhibit allograft rejec-
tion in an antigen-non-specific manner (23). We have also 
shown that CD8+CD122+ Treg-mediated suppression in vitro 
is donor-non-specific (24), supporting a finding by others 
that memory-like CD8+CD38+ T-cells suppress CD4+ T cell 
activation in an antigen-independent fashion (30). Therefore, 
it is possible that their suppression of immune responses is not 
antigen specific.
CD8+CD122+ Tregs inhibit immune 
Responses in Animal Models of Diseases
Early evidence has shown that CD8+CD122+ Tregs regulate 
T cell homeostasis (14), whereas recent studies have suggested 
that they play an important role in the suppression of autoim-
mune responses. Transfer of CD8+CD122+ Tregs significantly 
improved clinical symptoms of experimental autoimmune 
encephalomyelitis (EAE) (37), whereas IL-15-dependent 
CD8+CD122+ Tregs also ameliorated EAE by suppressing IL-17 
production (38). Dendritic cells (DCs) expressing B7-H1 mol-
ecule recruited CD8+CD122+ Tregs, which in turn suppressed 
the onset of EAE (39). CD8+CD38+CD122+ Tregs inhibited 
effector CD4+ T-cell activation and mitigated murine EAE by 
delaying the disease occurrence (30). Studies using HLA-DR3 
transgenic mice also demonstrated that CD8+CD122+ T-cells 
could regulate EAE (22). Depleting CD8+CD122+ T-cells 
augmented the incidence of autoimmune Graves’ hyperthy-
roidism (40). Interestingly, CD8+CD122+ and CD4+CD25+ 
Tregs cooperatively suppressed colitis mediated by CD4+ 
T-cells (19), whereas the systemic lupus erythematosus-like 
disease in B6-Yaa mutant mice was associated with a defect 
in CD8+CD122+ T-cells (21). Therefore, it has been clear that 
CD8+CD122+ Tregs play an essential role in the suppression of 
various experimental autoimmune diseases.
Emerging evidence has shown that memory-like 
CD8+CD122+ Tregs can also suppress alloimmune responses 
and allograft rejection. We have unveiled the first evidence 
that CD8+CD122+ Tregs suppress allograft rejection, whereas 
their PD-1+ component is more efficient than unfractionated 
CD8+CD122+ Treg population (24). Therefore, both 
CD4+CD25+ and CD8+CD122+ T-cells are Tregs that can 
inhibit allograft rejection. In order to seek more efficient Treg 
suppression for potential clinical applications, we determined 
the efficacy of CD8+CD122+ versus CD4+CD25+ Tregs in their 
suppression of allograft rejection. We found that CD8+CD122+ 
Tregs were actually more potent in suppression of allograft 
rejection and underwent faster homeostatic proliferation 
in  vivo than their CD4+CD25+ counterparts (27). Moreover, 
they also were more effective in the suppression of in  vitro 
T cell proliferation than their CD4+CD25+ counterparts. 
Importantly, the adoptive transfer of CD8+CD122+, but not 
CD4+CD25+, Tregs plus treatments with recombinant murine 
IL-15 significantly extended allograft survival even in immune 
competent wild-type mice (27). By contrast, the adoptive 
transfer of CD4+CD25+ Tregs, together with administration 
of recombinant IL-15, did not significantly suppress allograft 
rejection. We postulated that administering IL-15 promoted 
the expansion of transferred CD8+CD122+ Tregs, which in 
turn extended allograft survival. Krupnick et  al. found that 
costimulatory blockade-mediated long-term allograft accept-
ance was dependent on the rapid infiltration of the lung graft 
by central memory CD8+ T-cells and on their production of 
IFNγ, which in turn induced nitric oxide (NO) and inhibited 
alloimmune responses (25). Taken together, CD8+CD122+ 
Tregs with central memory phenotypes can regulate both 
autoimmunity and alloimmunity, suggesting an important 
role for CD8+CD122+ Tregs in the modulation of pathogenic 
immune responses.
Mechanisms Responsible for 
immunosuppression Mediated by 
CD8+CD122+ Tregs
Although CD8+CD122+ Tregs have been shown to suppress both 
alloimmune and autoimmune responses in animal models, their 
mechanisms of action are not fully understood. Endharti et al. 
have shown that CD8+CD122+ Tregs suppress proliferation of 
conventional CD8+ T-cells by producing IL-10 in vitro (15). Later 
on, both IL-10 and TGFβ1 produced by memory CD8+CD122+ 
Tregs were reportedly responsible for their suppressive activi-
ties (15, 23, 24, 41), as shown in Figure 1. CD8+CD122+ Tregs 
recognized conventional T cells via the interaction of MHC class 
I–αβ TCR and suppressed T-cell function by producing IL-10 
(41). We demonstrated that prolongation of allograft survival 
by IL-10-deficient CD8+CD122+ Tregs was largely diminished 
(24). Interestingly, both PD-1 and CD28 signaling pathways on 
CD8+CD122+ Tregs were required for their optimal production 
of IL-10 (24). Moreover, CD8+CD122+ Tregs released both IFNγ 
and TGFβ1 that suppressed CD4+ T cell activation (22). Krupnick 
et al. revealed that CCR7 expression on central memory CD8+ 
T-cells was critical for the formation of stable synapses with 
antigen-presenting cells, which resulted in the production of 
IFN-γ. The latter in turn induced nitric oxide, which down-
regulated alloimmune responses and suppressed lung allograft 
rejection (25). Importantly, CD8+CD122+ Tregs ameliorated EAE 
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via inhibiting IL-17 production by CD4+ effector T-cells, and 
their suppressive function was dependent on IL-15 (38). On the 
other hand, disruption of the inhibitory interaction between 
CD8+CD122+ T-cells and their target Qa-1+ follicular T-helper 
(Tfh) cells resulted in the development of a lethal systemic-lupus-
erythematosus-like autoimmune disease that was dependent on 
autoantibodies (42). Despite those findings, more studies are 
required to fully elucidate mechanisms underlying CD8+CD122+ 
Treg suppression. Fully understanding their mechanisms of 
action will help design effective approaches to treating allograft 
rejection and autoimmune diseases.
Concluding Remarks
Memory CD8+CD122+ T-cells have previously been considered 
to be antigen-specific memory T-cells (8–10). Especially, they 
exhibit central memory T-cell phenotypes. Mounting evidence 
has shown that they are also Tregs. Therefore, it is important to 
define how and when they act as memory versus Tregs. It has 
been known that abundant PD-1 expression on CD8+ T-cells rep-
resents their status of exhaustion during chronic viral infection, 
while PD-1 blockade restores their immune responses (43–46). 
Recent studies have also shown that T cells undergoing homeo-
static proliferation consist of both PD-1+ and PD-1− components. 
It  was PD-1+ subset of the T-cells that were dysfunctional 
(47). We have determined if CD8+CD122+ T-cells also contain 
both PD-1+ and PD-1− subsets. We found that CD8+CD122+ 
T-cells contained a subset of PD-1+ cell population that 
actually suppressed allograft rejection, while donor-specific 
PD-1−CD8+CD122+ T-cells were memory T-cells (24). Hence, 
PD-1 marker can be utilized to identify murine CD8+CD122+ 
Tregs. On the other hand, we have found that “bystander” cen-
tral memory CD8+ T-cells, which do not recognize a specific 
allograft, are true Tregs (23), whereas others have also shown 
that memory-like CD122+CD8+CD38+ T-cells suppress CD4+ 
T cell activation in an antigen-independent fashion, indicat-
ing that CD8+CD122+ Tregs act in an antigen-non-specific 
manner.
Murine CD8+CD122+ Tregs are naturally arising and 
exhibit a distribution pattern of two age-related phases. It 
is unclear if they can be induced from naïve CD8+ T-cells. 
Naturally occurring CD8+CD122+ Tregs can suppress both 
autoimmunity and alloimmunity in many animal models of 
diseases. Mechanisms underlying CD8+CD122+ Treg sup-
pression mainly include their production of IL-10, TGFβ1, 
IFNγ, etc. Although IL-15 drives the homeostatic expansion 
of murine CD8+CD122+ Tregs, it remains unknown what 
drives homeostatic proliferation of human CD8+CXCR3+ 
Tregs that do not express CD122, although both Tregs exhibit 
the phenotypes of central memory T-cells. Further studies are 
warranted to determine if human CD8+CXCR3+ Tregs can 
exert suppressive function in vivo.
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